Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ameris Bancorp Insiders Seem to Be Betting on This Pending Acquisition

Ameris Bancorp insidersJ Leo Hill, Director of the Board at Ameris Bancorp (NASDAQ:ABCB) acquired stock from the company on Wednesday and Thursday, after it publicly reported its third quarter results on October 21st.

Ameris Bancorp (NASDAQ:ABCB)

Amongst the highlights are: net income available to common shareholders of $0.26 per diluted share, compared to $0.04 per diluted share, for the same quarter last year; return on average assets of 0.94% and return on average tangible equity of 10.75% (both very close to industry averages); and an annualized growth rate of 8.62%, year-over-year, for non-covered loans .

Although the stock was up on Monday and Tuesday, following the announcement of the results, it dropped on Wednesday. On that day, Hill bought 1,500 shares at $17.93 each. As the stock price continued to decline, Hill added, on Thursday, another 915 shares to his portfolio at a price of $17.85 each. Following the reported transactions, the insider directly owns 4,415 shares, valued at approximately $79,161 (as of the market close of Oct. 24th).

These are not Hill’s first purchases this year. He had already bought shares in three occasions during March and has already perceived an upside of more than 25%. Besides Hill, another insider, D Jimmy Veal -also a Director- has bet on the firm this year. However, his luck wasn’t the same as Hill’s: he bought 525 shares in July at a price of $18.54 each, and shares now trade at $17.93.


Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Verastem’s Richard Aldrich Made a Buy Earlier This Week at $12.57/Share

Meet Dr. Phillip Frost, The Hypertrader of Opko Health

Global Payments Executives Are Making a Ton of Trades

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!